• Md. Abdul Aziz Bangladesh Shishu Hospital and Institute, Sher-E-Bangla Nagar, Dhaka-1207
  • Nabiha Tasneem Khan Department of Genetic Engineering and Biotechnology, University of Dhaka
  • Waqar Ahmed Khan Bangladesh Shishu Hospital and Institute, Sher-E-Bangla Nagar, Dhaka-1207
  • Mustak Ibn Ayub Department of Genetic Engineering and Biotechnology, University of Dhaka
  • Sabina Yeasmin Department of Genetic Engineering and Biotechnology, University of Dhaka



hemoglobin E-beta thalassemia, rare mutation, thalassemia


Thalassemia is one of the most common genetic disorders in Bangladesh. We have performed an investigation among 360 patients with Hb E/β-thalassemia to understand the heterogeneity in thalassemia severity among Bangladeshi patients. The analysis revealed that one of the common mutations CD26 (G>A) is found with two rare mutations HBB: c.-79A>G (-29A>G) and HBB: c.45_46insG (CD14/15 (+G)) in two patients individually which are not prevalent in geographically adjacent populations. Among these two rare mutations, -29A>G is located at the ‘TATA’ box region of the promoter sequence regulating transcription initiation and CD14/15 (+G) leads to a premature stop codon. We performed transcription factor binding site prediction analysis and found that ‘AP-1’, ‘c-Jun’, and ‘kr’ transcription factors bind at the ‘TATA’ box region. From this analysis, we can predict that -29A>G mutation can alter the level of HBB transcription whereas the CD14/15 (+G) mutation causes a truncated (and possibly non-functional) HBB protein. Aligned with such assumption, it was observed from patients’ medical history that, the patient who had CD14/15 (+G) and CD26 (G>A) mutations was severely blood transfusion-dependent whereas the patient carrying -29A>G and CD26 (G>A) mutations was moderately transfusion dependent. The comprehensive analysis of the mutations offers crucial insights and approaches for enhanced management of thalassemia among the Bangladeshi population.


Alam NE, Islam MS, Khabir MIU, et al. The scenario of knowledge, attitude and practice of the Bangladeshi population towards thalassemia prevention: A nationwide study. PLOS global public health. 2022;2(10), e0001177.

Antonarakis, S. E., Irkin, S. H., Cheng, T. C., Scott, A. F., Sexton, J. P., Trusko, S. P., Charache, S., & Kazazian, H. H., Jr (1984). Beta-Thalassemia in American Blacks: novel mutations in the "TATA" box and an acceptor splice site. Proceedings of the National Academy of Sciences of the United States of America, 81(4), 1154–1158.

Aziz, M. A., Khan, W. A., Banu, B., Das, S. A., Sadiya, S., & Begum, S. (2020). Prenatal Diagnosis and Screening of Thalassemia Mutations in Bangladesh: Presence of Rare Mutations. Hemoglobin, 44(6), 397–401.

Benz, E. J., Jr, Berman, B. W., Tonkonow, B. L., Coupal, E., Coates, T., Boxer, L. A., Altman, A., & Adams, J. G., 3rd (1981). Molecular analysis of the beta-thalassemia phenotype associated with inheritance of hemoglobin E (alpha 2 beta2(26)Glu leads to Lys). The Journal of clinical investigation, 68(1), 118–126.

Carlice-Dos-Reis, T., Viana, J., Moreira, F. C., Cardoso, G. L., Guerreiro, J., Santos, S., & Ribeiro-Dos-Santos, Â. (2017). Investigation of mutations in the HBB gene using the 1,000 genomes database. PloS one, 12(4), e0174637.

Carrocini, G. C. S., Venâncio, L. P. R., Pessôa, V., Lobo, C., & Bonini-Domingos, C. R. (2017). Mutational Profile of Homozygousβ-Thalassemia in Rio de Janeiro, Brazil. Hemoglobin.

Chan, V., Chan, T. K., Kan, Y. W., & Todd, D. (1988). A novel beta-thalassemia frameshift mutation (codon 14/15), detectable by direct visualization of abnormal restriction fragment in amplified genomic DNA. Blood, 72(4), 1420–1423.

Dreos, R., Ambrosini, G., Périer, R. C., & Bucher, P. (2015). The Eukaryotic Promoter Database: expansion of EPDnew and new promoter analysis tools. Nucleic acids research, 43(Database issue), D92–D96.

Farré, D., Roset, R., Huerta, M., Adsuara, J. E., Roselló, L., Albà, M. M., & Messeguer, X. (2003). Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic acids research, 31(13), 3651–3653.

Fraidenburg, D. R., & Machado, R. F. (2016). Pulmonary hypertension associated with thalassemia syndromes. Annals of the New York Academy of Sciences, 1368(1), 127–139.

Fucharoen, S., & Weatherall, D. J. (2012). The hemoglobin E thalassemias. Cold Spring Harbor perspectives in medicine, 2(8), a011734.

George, E. (2013). HBE Β-Thalassaemia in Malaysia: revisited. Journal of Hematology & Thromboembolic Diseases, 01(01).

Grabe N. (2002). AliBaba2: context specific identification of transcription factor binding sites. In silico biology, 2(1), S1–S15.

Gupta, S. K., Dass, J., & Saxena, R. (2015). A rare case of double heterozygous state for HbD and HbE. Indian Journal of Pathology & Microbiology, 58(1), 126.

Hamosh, A., Scott, A. F., Amberger, J. S., Bocchini, C. A., & McKusick, V. A. (2005). Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic acids research, 33(Database issue), D514–D517.

Hernaningsih, Y., Syafitri, Y., Indrasari, Y. N., Rahmawan, P. A., Andarsini, M. R., Lesmana, I., Moses, E. J., Abdul Rahim, N. A., & Yusoff, N. M. (2022). Analysis of Common Beta-Thalassemia (β-Thalassemia) Mutations in East Java, Indonesia. Frontiers in pediatrics, 10, 925599.

Lin, M., Jiao, J., Zhan, X., Zhan, X., Pan, M., Wang, J., Wang, C., Zhong, T., Zhang, Q., Yu, X., Wu, J., Yang, H., Lin, F., Tong, X., Yang, H., Zha, G., Wang, Q., Zheng, L., Wen, Y., & Yang, L. (2014). High Resolution Melting Analysis: A rapid screening and typing tool for common Β-Thalassemia mutation in Chinese population. PLOS ONE, 9(8), e102243.

Meng, Q., & Xia, Y. (2011). c-Jun, at the crossroad of the signaling network. Protein & cell, 2(11), 889–898.

Nuinoon, M., Kruachan, K., Sengking, W., Horpet, D., & Sungyuan, U. (2014). Thalassemia and hemoglobin e in southern thai blood donors. Advances in hematology, 2014, 932306.

Olivieri, N. F., Pakbaz, Z., & Vichinsky, E. (2011). Hb E/beta-thalassaemia: a common & clinically diverse disorder. The Indian journal of medical research, 134(4), 522–531.

Saad, H. K. M., Taib, W. R. W., Ab Ghani, A. S., Ismail, I., Al-Rawashde, F. A., Almajali, B., Alhawamdeh, M., Abd Rahman, A. A., Al-Wajeeh, A. S., & Al-Jamal, H. A. N. (2023). HBB Gene Mutations and Their Pathological Impacts on HbE/β-Thalassaemia in Kuala Terengganu, Malaysia. Diagnostics (Basel, Switzerland), 13(7), 1247.




How to Cite

Aziz, M. A., Khan, N. T., Khan, W. A., Ayub, M. I., & Yeasmin, S. (2023). REPORTING TWO RARE MUTATIONS WITH ASSOCIATED CLINICAL FEATURES IN BANGLADESHI HB E/Β THALASSEMIA PATIENTS. Bioresearch Communications - (BRC), 10(01), 1442–1448.



Original Article